RxDoctor Payments Data

Benjamin Jackson, MD

Vascular Surgery · Allentown, PANPI 1164588448

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (53.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Cook Incorporated accounts for 66.6% of it on its own, with 15 other manufacturers making up the rest.

$26,279in general payments, 2019–2025

Across 111 payments — averaging $236.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$18K
  • Cook Medical LLC$3K
  • W. L. Gore & Associates, Inc.$2K
  • Medtronic$932
  • Abbott$554
  • Endologix LLC$525
  • plus $2K from 10 others
$72,260in research payments, 2019–2025

Across 43 payments — averaging $1680.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cook Research Incorporated$39K
  • W. L. Gore & Associates, Inc.$20K
  • Endologix LLC$13K

What the payments were for

  • Consulting fees$3,17512%
  • Speaking & faculty fees$14,00053%
  • Travel & lodging$2,1078%
  • Food & beverage$6,99727%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,279 in reported general payments places this provider in the 85th percentile of 236 vascular surgery providers in Pennsylvania.

See all vascular surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$107,425
Medicare patients
231
Services billed
429

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate26$574

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Allentown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →